210 related articles for article (PubMed ID: 31721311)
1. The Janus Kinase inhibitor tofacitinib impacts human dendritic cell differentiation and favours M1 macrophage development.
Stalder R; Zhang B; Jean Wrobel L; Boehncke WH; Brembilla NC
Exp Dermatol; 2020 Jan; 29(1):71-78. PubMed ID: 31721311
[TBL] [Abstract][Full Text] [Related]
2. The JAK inhibitor, tofacitinib, reduces the T cell stimulatory capacity of human monocyte-derived dendritic cells.
Kubo S; Yamaoka K; Kondo M; Yamagata K; Zhao J; Iwata S; Tanaka Y
Ann Rheum Dis; 2014 Dec; 73(12):2192-8. PubMed ID: 24013646
[TBL] [Abstract][Full Text] [Related]
3. Suppression of IL-12/IL-23 p40 subunit in the skin and blood of psoriasis patients by Tofacitinib is dependent on active interferon-γ signaling in dendritic cells: Implications for the treatment of psoriasis and interferon-driven diseases.
Vincken NLA; Welsing PMJ; Silva-Cardoso SC; Bekker CPJ; Lopes AP; Olde Nordkamp M; Leijten EFA; Radstake TRDJ; Angiolilli C
Exp Dermatol; 2022 Jun; 31(6):962-969. PubMed ID: 35297512
[TBL] [Abstract][Full Text] [Related]
4. TLR2 stimulation impairs anti-inflammatory activity of M2-like macrophages, generating a chimeric M1/M2 phenotype.
Quero L; Hanser E; Manigold T; Tiaden AN; Kyburz D
Arthritis Res Ther; 2017 Nov; 19(1):245. PubMed ID: 29096690
[TBL] [Abstract][Full Text] [Related]
5. Combined anti-fibrotic and anti-inflammatory properties of JAK-inhibitors on macrophages in vitro and in vivo: Perspectives for scleroderma-associated interstitial lung disease.
Lescoat A; Lelong M; Jeljeli M; Piquet-Pellorce C; Morzadec C; Ballerie A; Jouneau S; Jego P; Vernhet L; Batteux F; Fardel O; Lecureur V
Biochem Pharmacol; 2020 Aug; 178():114103. PubMed ID: 32562787
[TBL] [Abstract][Full Text] [Related]
6. A JAK1 Selective Kinase Inhibitor and Tofacitinib Affect Macrophage Activation and Function.
De Vries LCS; Duarte JM; De Krijger M; Welting O; Van Hamersveld PHP; Van Leeuwen-Hilbers FWM; Moerland PD; Jongejan A; D'Haens GR; De Jonge WJ; Wildenberg ME
Inflamm Bowel Dis; 2019 Mar; 25(4):647-660. PubMed ID: 30668755
[TBL] [Abstract][Full Text] [Related]
7. An in vitro test system for compounds that modulate human inflammatory macrophage polarization.
Shiratori H; Feinweber C; Luckhardt S; Wallner N; Geisslinger G; Weigert A; Parnham MJ
Eur J Pharmacol; 2018 Aug; 833():328-338. PubMed ID: 29920284
[TBL] [Abstract][Full Text] [Related]
8. Bicarbonate enhances the inflammatory response by activating JAK/STAT signalling in LPS + IFN-γ-stimulated macrophages.
Kawakami T; Koike A; Maehara T; Hayashi T; Fujimori K
J Biochem; 2020 Jun; 167(6):623-631. PubMed ID: 31960927
[TBL] [Abstract][Full Text] [Related]
9. Notch signaling triggered via the ligand DLL4 impedes M2 macrophage differentiation and promotes their apoptosis.
Pagie S; Gérard N; Charreau B
Cell Commun Signal; 2018 Jan; 16(1):4. PubMed ID: 29321062
[TBL] [Abstract][Full Text] [Related]
10. Tofacitinib Reprograms Human Monocytes of IBD Patients and Healthy Controls Toward a More Regulatory Phenotype.
Cordes F; Lenker E; Spille LJ; Weinhage T; Bettenworth D; Kessel C; Schmidt HH; Foell D; Varga G
Inflamm Bowel Dis; 2020 Feb; 26(3):391-406. PubMed ID: 31560043
[TBL] [Abstract][Full Text] [Related]
11. The JAK Inhibitor Tofacitinib Rescues Intestinal Barrier Defects Caused by Disrupted Epithelial-macrophage Interactions.
Spalinger MR; Sayoc-Becerra A; Ordookhanian C; Canale V; Santos AN; King SJ; Krishnan M; Nair MG; Scharl M; McCole DF
J Crohns Colitis; 2021 Mar; 15(3):471-484. PubMed ID: 32909045
[TBL] [Abstract][Full Text] [Related]
12. Tofacitinib Affects M1-like and M2-like Polarization and Tissue Factor Expression in Macrophages of Healthy Donors and IBD Patients.
Lethen I; Lechner-Grimm K; Gabel M; Knauss A; Atreya R; Neurath MF; Weigmann B
Inflamm Bowel Dis; 2023 Dec; ():. PubMed ID: 38142236
[TBL] [Abstract][Full Text] [Related]
13. Monocyte-Derived Dendritic Cell Differentiation in Inflammatory Arthritis Is Regulated by the JAK/STAT Axis via NADPH Oxidase Regulation.
Marzaioli V; Canavan M; Floudas A; Wade SC; Low C; Veale DJ; Fearon U
Front Immunol; 2020; 11():1406. PubMed ID: 32733468
[TBL] [Abstract][Full Text] [Related]
14. Role of JAK-STAT signaling in the pathogenic behavior of fibroblast-like synoviocytes in rheumatoid arthritis: Effect of the novel JAK inhibitor peficitinib.
Emori T; Kasahara M; Sugahara S; Hashimoto M; Ito H; Narumiya S; Higashi Y; Fujii Y
Eur J Pharmacol; 2020 Sep; 882():173238. PubMed ID: 32561292
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulating role of the JAKs inhibitor tofacitinib in a mouse model of bleomycin-induced scleroderma.
Aung WW; Wang C; Xibei J; Horii M; Mizumaki K; Kano M; Okamura A; Kobayashi T; Matsushita T
J Dermatol Sci; 2021 Mar; 101(3):174-184. PubMed ID: 33451905
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory Effects of Four Leishmania infantum Potentially Excreted/Secreted Proteins on Human Dendritic Cells Differentiation and Maturation.
Markikou-Ouni W; Drini S; Bahi-Jaber N; Chenik M; Meddeb-Garnaoui A
PLoS One; 2015; 10(11):e0143063. PubMed ID: 26581100
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of JAK-STAT Signaling Suppresses Pathogenic Immune Responses in Medium and Large Vessel Vasculitis.
Zhang H; Watanabe R; Berry GJ; Tian L; Goronzy JJ; Weyand CM
Circulation; 2018 May; 137(18):1934-1948. PubMed ID: 29254929
[TBL] [Abstract][Full Text] [Related]
18. Impact of Janus Kinase Inhibition with Tofacitinib on Fundamental Processes of Bone Healing.
Gaber T; Brinkman ACK; Pienczikowski J; Diesing K; Damerau A; Pfeiffenberger M; Lang A; Ohrndorf S; Burmester GR; Buttgereit F; Hoff P
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013232
[TBL] [Abstract][Full Text] [Related]
19. Polarization profiles of human M-CSF-generated macrophages and comparison of M1-markers in classically activated macrophages from GM-CSF and M-CSF origin.
Jaguin M; Houlbert N; Fardel O; Lecureur V
Cell Immunol; 2013 Jan; 281(1):51-61. PubMed ID: 23454681
[TBL] [Abstract][Full Text] [Related]
20. The Janus kinase inhibitor tofacitinib inhibits TNF-α-induced gliostatin expression in rheumatoid fibroblast-like synoviocytes.
Kawaguchi Y; Waguri-Nagaya Y; Tatematsu N; Oguri Y; Kobayashi M; Nozaki M; Asai K; Aoyama M; Otsuka T
Clin Exp Rheumatol; 2018; 36(4):559-567. PubMed ID: 29352846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
